In recognition of the economic impact of COVID-19, ASPET’s Board of Publications Trustees voted to freeze the Society’s institutional subscription prices for 2021. 

These are extraordinary times for libraries, universities, businesses, and, indeed, the world. ASPET recognizes that upcoming budgets will be affected and that both short- and long-term planning are difficult, at best. The Society is committed to working through this time and doing all that we can to make journals access a continued possibility for our institutional subscribers.

Full access to DMD, JPET, Molecular Pharmacology, and Pharmacological Reviews is a benefit of ASPET membership. Members who need help accessing the journals should contact subscriptions@aspet.org. ASPET staff are working remotely to continue serving the Society’s members and will gladly assist you.